Voiceitt, founded in Ramat Gan, Israel in 2012 by Danny Weissberg, Stas Tiomkin and Sara Smolley, develops an automatic speech-recognition engine specifically trained to understand atypical and dysarthric speech — the non-standard speech patterns produced by conditions such as cerebral palsy, stroke, Parkinson's disease or Down syndrome. Rather than the conventional phoneme-by-phoneme pipeline used by mainstream voice assistants, Voiceitt's convolutional neural network analyses larger chunks of a user's acoustic signal holistically, letting each user train a personalised model by repeating phrases until the system recognises them reliably.
The technology is integrated directly into Amazon Alexa — the Alexa Fund was an early investor — so a trained phrase can control smart-home devices such as lights, TVs or music. In a 2019 pilot at the Inglis House residential-care community in Philadelphia, participants with cerebral palsy and atypical speech reportedly controlled their environment within minutes of starting to train the app. A subsequent, independently funded trial, run by the UK charity Ace Centre with support from the NHS Health Innovation Manchester Momentum Fund, had eight participants use Voiceitt for at least three months to assess whether it could improve communication, independence and quality of life.
The Ace Centre write-up is honest about mixed results: some participants valued the Alexa smart-home control, while others found the requirement to pre-train and repeat fixed phrases limiting for spontaneous conversation. No sample size beyond single digits, and no controlled comparison group, has been publicly reported, so Voiceitt's real-world effectiveness at scale remains only lightly evidenced — a genuine, if modest, gain in independence for a severely underserved population, rather than a fully proven intervention.
Read the full analysis: https://www.voiceitt.com/
Where this practice's information was retrieved from, and when.